Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.
J. Clin. Invest. S Vrtala, et al. 99:1673
doi:10.1172/JCI119330 [Go to this article.]

Problems with a PDF?